Cargando…
Repurposing traditional immunomodulators to target the inflammatory burden of atherosclerosis()
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214290/ https://www.ncbi.nlm.nih.gov/pubmed/32399483 http://dx.doi.org/10.1016/j.ijcha.2020.100535 |
_version_ | 1783531936235388928 |
---|---|
author | Fender, Anke C. Dobrev, Dobromir |
author_facet | Fender, Anke C. Dobrev, Dobromir |
author_sort | Fender, Anke C. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7214290 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-72142902020-05-12 Repurposing traditional immunomodulators to target the inflammatory burden of atherosclerosis() Fender, Anke C. Dobrev, Dobromir Int J Cardiol Heart Vasc Editorial Elsevier 2020-05-12 /pmc/articles/PMC7214290/ /pubmed/32399483 http://dx.doi.org/10.1016/j.ijcha.2020.100535 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Editorial Fender, Anke C. Dobrev, Dobromir Repurposing traditional immunomodulators to target the inflammatory burden of atherosclerosis() |
title | Repurposing traditional immunomodulators to target the inflammatory burden of atherosclerosis() |
title_full | Repurposing traditional immunomodulators to target the inflammatory burden of atherosclerosis() |
title_fullStr | Repurposing traditional immunomodulators to target the inflammatory burden of atherosclerosis() |
title_full_unstemmed | Repurposing traditional immunomodulators to target the inflammatory burden of atherosclerosis() |
title_short | Repurposing traditional immunomodulators to target the inflammatory burden of atherosclerosis() |
title_sort | repurposing traditional immunomodulators to target the inflammatory burden of atherosclerosis() |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214290/ https://www.ncbi.nlm.nih.gov/pubmed/32399483 http://dx.doi.org/10.1016/j.ijcha.2020.100535 |
work_keys_str_mv | AT fenderankec repurposingtraditionalimmunomodulatorstotargettheinflammatoryburdenofatherosclerosis AT dobrevdobromir repurposingtraditionalimmunomodulatorstotargettheinflammatoryburdenofatherosclerosis |